Compare LAW & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAW | OSUR |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.9M | 256.6M |
| IPO Year | 2021 | 2000 |
| Metric | LAW | OSUR |
|---|---|---|
| Price | $5.72 | $3.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.00 | $5.50 |
| AVG Volume (30 Days) | 291.8K | ★ 611.5K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.58 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $156,849,000.00 | ★ $167,064,000.00 |
| Revenue This Year | $12.74 | $4.64 |
| Revenue Next Year | $10.55 | $9.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.29 | N/A |
| 52 Week Low | $2.45 | $2.08 |
| 52 Week High | $9.11 | $4.58 |
| Indicator | LAW | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 47.50 |
| Support Level | $3.49 | $2.86 |
| Resistance Level | $6.39 | $4.11 |
| Average True Range (ATR) | 0.37 | 0.25 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 44.97 | 43.75 |
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.